| In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape R García-Álvarez, M Hadjidemetriou, A Sánchez-Iglesias, LM Liz-Marzán, ... Nanoscale 10 (3), 1256-1264, 2018 | 384 | 2018 |
| In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles M Hadjidemetriou, Z Al-Ahmady, M Mazza, RF Collins, K Dawson, ... ACS nano 9 (8), 8142-8156, 2015 | 356 | 2015 |
| Evolution of the nanoparticle corona M Hadjidemetriou, K Kostarelos Nature nanotechnology 12 (4), 288-290, 2017 | 329 | 2017 |
| Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles M Hadjidemetriou, Z Al-Ahmady, K Kostarelos Nanoscale 8 (13), 6948-6957, 2016 | 223 | 2016 |
| The human in vivo biomolecule corona onto PEGylated liposomes: a proof‐of‐concept clinical study M Hadjidemetriou, S McAdam, G Garner, C Thackeray, D Knight, D Smith, ... Advanced Materials 31 (4), 1803335, 2019 | 161 | 2019 |
| Nanotools for sepsis diagnosis and treatment L Papafilippou, A Claxton, P Dark, K Kostarelos, M Hadjidemetriou Advanced healthcare materials 10 (1), 2001378, 2021 | 87 | 2021 |
| Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes ZS Al-Ahmady, M Hadjidemetriou, J Gubbins, K Kostarelos Journal of Controlled Release 276, 157-167, 2018 | 85 | 2018 |
| A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona M Hadjidemetriou, Z Al-Ahmady, M Buggio, J Swift, K Kostarelos Biomaterials 188, 118-129, 2019 | 82 | 2019 |
| Protein corona fingerprinting to differentiate sepsis from non-infectious systemic inflammation L Papafilippou, A Claxton, P Dark, K Kostarelos, M Hadjidemetriou Nanoscale 12 (18), 10240-10253, 2020 | 59 | 2020 |
| Peptide nanofiber complexes with siRNA for deep brain gene silencing by stereotactic neurosurgery M Mazza, M Hadjidemetriou, I De Lázaro, C Bussy, K Kostarelos ACS nano 9 (2), 1137-1149, 2015 | 46 | 2015 |
| Nano-omics: nanotechnology-based multidimensional harvesting of the blood-circulating cancerome L Gardner, K Kostarelos, P Mallick, C Dive, M Hadjidemetriou Nature Reviews Clinical Oncology 19 (8), 551-561, 2022 | 37 | 2022 |
| Nano-scavengers for blood biomarker discovery in ovarian carcinoma M Hadjidemetriou, L Papafilippou, RD Unwin, J Rogan, A Clamp, ... Nano Today 34, 100901, 2020 | 28 | 2020 |
| Nanoparticle-enabled enrichment of longitudinal blood proteomic fingerprints in Alzheimer’s disease M Hadjidemetriou, J Rivers-Auty, L Papafilippou, J Eales, KAB Kellett, ... ACS nano 15 (4), 7357-7369, 2021 | 25 | 2021 |
| The biomolecule corona of lipid nanoparticles contains circulating cell-free DNA L Gardner, J Warrington, J Rogan, DG Rothwell, G Brady, C Dive, ... Nanoscale horizons 5 (11), 1476-1486, 2020 | 23 | 2020 |
| Incorporation of dimethoxycurcumin into charged liposomes and the formation kinetics of fractal aggregates of uncharged vectors M Hadjidemetriou, N Pippa, S Pispas, C Demetzos Journal of Liposome Research 23 (2), 94-100, 2013 | 20 | 2013 |
| First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses JPM Andrews, SS Joshi, E Tzolos, MB Syed, H Cuthbert, LE Crica, ... Nature Nanotechnology, 1-10, 2024 | 19 | 2024 |
| The challenge of recognising sepsis: Future nanotechnology solutions A Claxton, L Papafilippou, M Hadjidemetriou, K Kostarelos, P Dark Journal of the Intensive Care Society 21 (3), 241-246, 2020 | 12 | 2020 |
| Detection of cancer biomarkers using nanoparticles K Kostarelos, M Hadjidemetriou US Patent 11,598,779, 2023 | 10 | 2023 |
| Hampering brain tumor proliferation and migration using peptide nanofiber:siPLK1/MMP2 complexes M Mazza, H Ahmad, M Hadjidemetriou, G Agliardi, ON Pathmanaban, ... Nanomedicine 14 (24), 3127-3142, 2019 | 8 | 2019 |
| In vivo biomolecule corona and the transformation of a foe into an ally for nanomedicine M Hadjidemetriou, M Mahmoudi, K Kostarelos Nature Reviews Materials 9 (4), 219-222, 2024 | 6 | 2024 |
Kostas KostarelosNanomedicine Lab, ICREA & ICN2, Barcelona, Spain and University of Manchester, UKAdresse e-mail validée de icn2.cat
